Literature DB >> 33547938

Robotic-Assisted Navigation Bronchoscopy as a Paradigm Shift in Peripheral Lung Access.

Bryan S Benn1, Arthur O Romero2,3, Mendy Lum4, Ganesh Krishna2,4,5.   

Abstract

INTRODUCTION: The sensitivity of suspicious lung nodules biopsied by currently available techniques is suboptimal. Robotic-assisted navigation bronchoscopy (RANB) is a novel method for biopsying lung nodules. Our study objective was to determine the sensitivity for malignancy and overall diagnostic accuracy for RANB when combined with cone beam CT (CBCT) for secondary confirmation.
METHODS: 52 consecutive patients were prospectively enrolled. Demographic data, nodule characteristics, procedural information, and follow-up results were obtained.
RESULTS: Mean patient age was 66, with the majority Caucasian (73%) females (65%) with a similar number of never (46%) and former (46%) smokers. 15 patients had a history of cancer and 3 had a prior thoracic surgery. 59 total nodules were included as 7 patients had two nodules biopsied. Mean nodule diameter was < 2 cm in all dimension with the majority solid (41, 70%) and located in the upper lobes (left: 22, 37%; right: 17, 29%). Bronchus sign was absent (32, 54%) or present (27, 46%) in a similar number. All nodules were successfully reached with nine (15%) requiring minor directional changes after initial cone beam CT. A tissue diagnosis was obtained in 83% (49/59) of biopsied nodules, with malignancy (31, 65%) most common. Including all biopsy results and follow-up imaging, we obtained an 84% (31/37) procedural sensitivity for malignancy and an overall 86% (51/59) diagnostic yield.
CONCLUSION: RANB with CBCT increases sensitivity for malignancy and diagnostic accuracy of lung nodule biopsies. Combining these modalities has the potential to shift the diagnostic approach to pulmonary nodules.

Entities:  

Keywords:  Cone beam CT; Lung cancer; Lung nodule; Robotic bronchoscopy

Year:  2021        PMID: 33547938     DOI: 10.1007/s00408-021-00421-1

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  1 in total

1.  Prevention of atelectasis formation during the induction of general anesthesia in morbidly obese patients.

Authors:  Marta Coussa; Stefania Proietti; Pierre Schnyder; Philippe Frascarolo; Michel Suter; Donat R Spahn; Lennart Magnusson
Journal:  Anesth Analg       Date:  2004-05       Impact factor: 5.108

  1 in total
  6 in total

1.  Shape-Sensing Robotic-Assisted Bronchoscopy in the Diagnosis of Pulmonary Parenchymal Lesions.

Authors:  Or Kalchiem-Dekel; James G Connolly; I-Hsin Lin; Bryan C Husta; Prasad S Adusumilli; Jason A Beattie; Darren J Buonocore; Joseph Dycoco; Paige Fuentes; David R Jones; Robert P Lee; Bernard J Park; Gaetano Rocco; Mohit Chawla; Matthew J Bott
Journal:  Chest       Date:  2021-08-09       Impact factor: 9.410

2.  Combining Shape-Sensing Robotic Bronchoscopy With Mobile Three-Dimensional Imaging to Verify Tool-in-Lesion and Overcome Divergence: A Pilot Study.

Authors:  Janani Reisenauer; Jennifer D Duke; Ryan Kern; Sebastian Fernandez-Bussy; Eric Edell
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2022-04-23

3.  Efficacy and Safety of Cone-Beam CT Augmented Electromagnetic Navigation Guided Bronchoscopic Biopsies of Indeterminate Pulmonary Nodules.

Authors:  Shreya Podder; Sana Chaudry; Harpreet Singh; Elise M Jondall; Jonathan S Kurman; Bryan S Benn
Journal:  Tomography       Date:  2022-08-18

Review 4.  Anesthesia considerations to reduce motion and atelectasis during advanced guided bronchoscopy.

Authors:  Michael A Pritchett; Kelvin Lau; Scott Skibo; Karen A Phillips; Krish Bhadra
Journal:  BMC Pulm Med       Date:  2021-07-17       Impact factor: 3.317

Review 5.  Single-Use and Reusable Flexible Bronchoscopes in Pulmonary and Critical Care Medicine.

Authors:  Elliot Ho; Ajay Wagh; Kyle Hogarth; Septimiu Murgu
Journal:  Diagnostics (Basel)       Date:  2022-01-12

6.  LUNG Year in Review: 2021.

Authors:  Peter V Dicpinigaitis
Journal:  Lung       Date:  2022-01-18       Impact factor: 3.777

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.